✦ LIBER ✦

Memantine: A New Approach to Alzheimer's Disease

✍ Scribed by Norman L. Keltner; Beth Williams

Book ID: 111321310
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 109 KB
Volume: 40
Category: Article
ISSN: 0031-5990
DOI: 10.1111/j.1744-6163.2004.tb00007.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Memantine in moderate to severe Alzheime

Memantine in moderate to severe Alzheimer’s disease

✍ Andrew Kertesz 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 67 KB

A New Approach to Treating Alzheimer's D

A New Approach to Treating Alzheimer's Disease

✍ John P. Blass 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Memantine approved to treat moderate to

Memantine approved to treat moderate to severe Alzheimer’s disease

✍ Karen Marder 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 99 KB

Memantine enhances autonomy in moderate

Memantine enhances autonomy in moderate to severe Alzheimer's disease

✍ Benoît Rive; Martine Vercelletto; Florence Delamarre Damier; John Cochran; Cléme 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract ## Background Alzheimer's disease (AD) is the leading cause of dementia and its course renders patients functionally disabled. Memantine is the first drug to demonstrate a clinical benefit in the treatment of patients with moderately‐severe to severe AD. ## Objectives Our objective w

Donepezil and Memantine for Moderate-to-

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

✍ Howard, Robert; McShane, Rupert; Lindesay, James; Ritchie, Craig; Baldwin, Ashle 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 676 KB

Memantine benefits functional abilities

Memantine benefits functional abilities in moderate to severe Alzheimer’s disease

✍ Bengt Winblad; S. Gauthier; D. Åström; K. Stender 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 210 KB